Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells

European Journal of Pharmacology

Volumn 749, Issue , 2015, Pages 20-31

  Weaver, Erika M ^a   Zamora, Francis J ^a   Puplampu Dove, Yvonne A ^a   Kiessu, Ezechielle ^a   Hearne, Jennifer L ^a   Martin Caraballo, Miguel ^a  

^a UNIVERSITY OF MARYLAND EASTERN SHORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CALCIUM CHANNEL T TYPE; PACLITAXEL; T TYPE CALCIUM CHANNEL CAV3.2; THAPSIGARGIN; UNCLASSIFIED DRUG; CACNA1H PROTEIN, HUMAN; HISTONE DEACETYLASE INHIBITOR;

ARTICLE; CALCIUM CURRENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; LYMPH NODE CARCINOMA OF THE PROSTATE; PROSTATE CANCER CELL LINE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; GENETICS; HUMAN; MALE; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

BUTYRIC ACID; CALCIUM CHANNELS, T-TYPE; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HISTONE DEACETYLASE INHIBITORS; HUMANS; MALE; PACLITAXEL; PROSTATIC NEOPLASMS; THAPSIGARGIN;

EID: 84921421653     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.12.021     Document Type: Article

References (44)

1. Y.J. Bang, F. Pirnia, W.G. Fang, W.K. Kang, O. Sartor, L. Whitesell, M.J. Ha, M. Tsokos, M.D. Sheahan, P. Nguyen, W.T. Niklinski, C.E. Myers, and J.B. Trepel Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP Proc. Natl. Acad. Sci. USA 91 12 1994 5330 5334
2. J. Chemin, A. Traboulsie, and P. Lory Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones Cell Calcium. 40 2 2006 121 134
3. J. Chemin, J. Nargeot, and P. Lory Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line J. Neurosci. 22 16 2002 6856 6862
4. J. Chemin, A. Monteil, C. Briquaire, S. Richard, E. Perez-Reyes, J. Nargeot, and P. Lory Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation FEBS Lett. 478 1-2 2000 166 172
5. M.E. Cox, P.D. Deeble, E.A. Bissonette, and S.J. Parsons Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line J. Biol. Chem. 275 18 2000 13812 13818
6. M.E. Cox, P.D. Deeble, S. Lakhani, and S.J. Parsons Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression Cancer Res. 59 15 1999 3821 3830
7. 2+ channel gene family Circ. Res. 83 1 1998 103 109
8. J.H. Cummings, E.W. Pomare, W.J. Branch, C.P. Naylor, and G.T. Macfarlane Short chain fatty acids in human large intestine, portal, hepatic and venous blood Gut 28 10 1987 1221 1227
9. 2+ channels Am. J. Physiol.-Cell Physiol. 300 2011 C576 C587
10. L. D'Aiuto, R. De Marco, N. Edward, A. Rizzo, J.R. Chaillet, A. Montecalvo, M.T. Lotze, and A. Gambotto Evidence of the capability of the CMV enhancer to activate in trans gene expression in mammalian cells DNA Cell Biol. 25 3 2006 171 180
11. P.A. Di Sant'Agnese, and A.T. Cockett The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research J. Urol. 152 5 Pt 2 1994 1927 1931
12. C. Dubois, F. Vanden Abeele, P. Sehgal, C. Olesen, S. Junker, S.B. Christensen, N. Prevarskaya, and J.V. Møller Differential effects of thapsigargin analogues on apoptosis of prostate cancer cells: complex regulation by intracellular calcium FEBS J. 280 21 2013 5430 5440
13. 2+ homeostasis of advanced prostate cancer cells Biochim. Biophys. Acta 1793 6 2009 1105 1109
14. F. Gackière, M. Warnier, M. Katsogiannou, S. Derouiche, P. Delcourt, E. Dewailly, C. Slomianny, S. Humez, N. Prevarskaya, M. Roudbaraki, and P. Mariot Functional coupling between large-conductance potassium channels and Cav3.2 voltage-dependent calcium channels participates in prostate cancer cell growth Biol. Open 2 9 2013 941 951
15. F. Gackière, G. Bidaux, P. Lory, N. Prevarskaya, and P. Mariot A role for voltage gated T-type calcium channels in mediating capacitative calcium entry? Cell Calcium 39 4 2006 357 366
16. B.F. Hinnebusch, S. Meng, J.T. Wu, S.Y. Archer, and R.A. Hodin The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation J. Nutr. 132 5 2002 1012 1017
17. L. Huang, B.M. Keyser, T.M. Tagmose, J.B. Hansen, J.T. Taylor, H. Zhuang, M. Zhang, D.S. Ragsdale, and M. Li NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels J. Pharmacol. Exp. Ther. 309 1 2004 193 199
18. H.W. Kang, J.Y. Park, S.W. Jeong, J.A. Kim, H.J. Moon, E. Perez-Reyes, and J.H. Lee A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels J. Biol. Chem. 281 8 2006 4823 4830
19. J. Kim, H. Park, J.Y. Im, W.S. Choi, and H.S. Kim Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells Anticancer Res. 27 5A 2007 3285 3292
20. 2+channels Eur. J. Neurosci. 11 12 1999 4171 4178
21. A. Komiya, H. Suzuki, T. Imamoto, N. Kamiya, N. Nihei, Y. Naya, T. Ichikawa, and H. Fuse Neuroendocrine differentiation in the progression of prostate cancer Int. J. Urol. 16 1 2009 37 44
22. J.H. Lee, J.C. Gomora, L.L. Cribbs, and E. Perez-Reyes Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H Biophys. J. 77 6 1999 3034 3042
23. W. Li, S.L. Zhang, N. Wang, B.B. Zhang, and M. Li Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation Cancer Investig. 29 5 2011 339 346
24. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 4 2001 402 408
25. M. Mandal, and R. Kumar Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells Cell Growth Differ. 7 3 1996 311 318
26. P. Mariot, K. Vanoverberghe, N. Lalevee, M.F. Rossier, and N. Prevarskaya Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells J. Biol. Chem. 277 13 2002 10824 10833
27. F. Marger, A. Gelot, A. Alloui, J. Matricon, J.F. Ferrer, C. Barrère, A. Pizzoccaro, E. Muller, J. Nargeot, T.P. Snutch, A. Eschalier, E. Bourinet, and D. Ardid T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome Proc. Natl. Acad. Sci. USA 108 27 2011 11268 11273
28. J.E. McRory, C.M. Santi, K.S. Hamming, J. Mezeyova, K.G. Sutton, D.L. Baillie, A. Stea, and T.P. Snutch Molecular and functional characterization of a family of rat brain T-type calcium channels J. Biol. Chem. 276 6 2001 3999 4011
29. S. Mori, K. Murakami-Mori, and B. Bonavida Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells Biochem. Biophys. Res. Commun. 257 2 1999 609 614
30. T. Ohkubo, and J. Yamazaki T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells Int. J. Oncol. 41 1 2012 267 275
31. 2+ channels in embryonic chick nodose ganglion neurons Dev. Neurobiol. 67 14 2007 1901 1914
32. B. Pajak, A. Orzechowski, and B. Gajkowska Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells Adv. Med. Sci. 52 2007 83 88
33. Z. Pan, A. Avila, and L. Gollahon Paclitaxel induces apoptosis in breast cancer cells through different calcium - regulating mechanisms depending on external calcium conditions Int. J. Mol. Sci. 15 2 2014 2672 2694
34. L. Paskova, K. Smesny Trtkova, B. Fialova, A. Benedikova, K. Langova, and Z. Kolar Different effect of sodium butyrate on cancer and normal prostate cells Toxicol. In Vitro 27 5 2013 1489 1495
35. E. Perez-Reyes, L.L. Cribbs, A. Daud, A.E. Lacerda, J. Barclay, M.P. Williamson, M. Fox, M. Rees, and J.H. Lee Molecular characterization of a neuronal low-voltage-activated T-type calcium channel Nature 391 6670 1998 896 900
36. N. Prevarskaya, L. Zhang, and G. Barritt TRP channels in cancer Biochim. Biophys. Acta 1772 8 2007 937 946
37. 2+ transport in cancer: how it contributes to cancer hallmarks? Philos. Trans. R. Soc. Lond. B: Biol. Sci. 369 1638 2014 20130097
38. J. Qiu, Z. Gao, and H. Shima Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis Oncol. Rep. 27 1 2012 160 167
39. L. Sagnak, H. Topaloglu, U. Ozok, and H. Ersoy Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma Clin. Genitourin. Cancer 9 2 2011 73 80
40. S. Sarkar, A.L. Abujamra, J.E. Loew, L.W. Forman, S.P. Perrine, and D.V. Faller Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling Anticancer Res. 31 9 2011 2723 2732
41. W.R. Treem, N. Ahsan, G. Kastoff, and J.S. Hyams Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation J. Pediatr. Gastroenterol. Nutr. 23 3 1996 280 286
42. 2+ channels in chicken nodose neurons J. Neurochem. 108 1 2009 246 259
43. S. Zeissig, A. Fromm, J. Mankertz, J. Weiske, M. Zeitz, M. Fromm, and J.D. Schulzke Butyrate induces intestinal sodium absorption via Sp3-mediated transcriptional up-regulation of epithelial sodium channels Gastroenterology 132 1 2007 236 248
44. S. Zelivianski, M. Verni, C. Moore, D. Kondrikov, R. Taylor, and M.F. Lin Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype Biochim. Biophys. Acta 1539 1-2 2001 28 43